Developing Compelling Global Health Policy Narratives and Supporting Evidence

As a part of its global therapeutic area (TA) health policy initiatives, a leading biopharma company needed a new and improved narrative and evidence deck to impress upon policymakers and other critical stakeholders the importance of timely diagnosis and treatment of a specific disease. The materials were structured in three sections:

  1. Making the case for change for policy makers
  2. Giving reasons to believe effective policy solutions are available
  3. Issuing a call to action by policy makers

BTG delivered a senior health policy consultant to analyze the current research and materials to better understand the burden and impact of the disease. The consultant then created a TA-specific health policy narrative for both U.S. and ex-U.S. markets, developed a one-page leave-behind tailored to each market, and built an external evidence deck for presentation at regional franchise meetings.

 

Previous Article
The State of Enterprise Blockchain and Decentralized Finance
The State of Enterprise Blockchain and Decentralized Finance

Senior IT consultant, executive, and blockchain expert Peter Wokwicz joins us to discuss a few of the bigge...

Next Article
Digital Health Strategy Refresh
Digital Health Strategy Refresh

An F200 pharma company wanted to implement next generation digital health technologies, which required a th...